ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity.
Zamora I, Gutiérrez M, Pascual A, Pajares MJ, Barajas M, Perez LM, You S, Knudsen BS, Freeman MR, Encío IJ, Rotinen M.
Zamora I, et al.
Cell Oncol (Dordr). 2024 May 31. doi: 10.1007/s13402-024-00957-3. Online ahead of print.
Cell Oncol (Dordr). 2024.
PMID: 38819630